NexGel Debt to Equity Ratio 2021-2025 | NXGL
Current and historical debt to equity ratio values for NexGel (NXGL) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. NexGel debt/equity for the three months ending March 31, 2025 was 0.15.
| NexGel Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $0.01B | $0.01B | 0.87 |
| 2024-12-31 | $0.01B | $0.01B | 0.81 |
| 2024-09-30 | $0.01B | $0.01B | 1.12 |
| 2024-06-30 | $0.01B | $0.01B | 1.16 |
| 2024-03-31 | $0.01B | $0.01B | 1.00 |
| 2023-12-31 | $0.01B | $0.01B | 0.93 |
| 2023-09-30 | $0.00B | $0.01B | 0.59 |
| 2023-06-30 | $0.00B | $0.01B | 0.56 |
| 2023-03-31 | $0.00B | $0.01B | 0.50 |
| 2022-12-31 | $0.00B | $0.01B | 0.36 |
| 2022-09-30 | $0.00B | $0.01B | 0.37 |
| 2022-06-30 | $0.00B | $0.01B | 0.47 |
| 2022-03-31 | $0.00B | $0.01B | 0.37 |
| 2021-12-31 | $0.01B | $0.01B | 0.41 |
| 2021-09-30 | $0.00B | $0.00B | 9.21 |
| 2021-06-30 | $0.00B | $0.00B | 14.28 |
| 2021-03-31 | $0.00B | $0.00B | 2.43 |
| 2020-12-31 | $0.00B | $0.00B | 30.79 |
| 2020-09-30 | $0.00B | $0.00B | 0.00 |
| 2020-06-30 | $0.00B | $0.00B | 0.00 |
| 2020-03-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.018B | $0.009B |
| NexGel Inc. is a provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. The company developed and manufactured electron-beam, cross-linked hydrogels. NexGel Inc. is based in Langhorne, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $182.012B | 22.03 |
| Intuitive Surgical (ISRG) | United States | $178.116B | 73.83 |
| Edwards Lifesciences (EW) | United States | $47.204B | 31.31 |
| IDEXX Laboratories (IDXX) | United States | $46.087B | 52.96 |
| Alcon (ALC) | Switzerland | $45.102B | 30.48 |
| DexCom (DXCM) | United States | $35.035B | 54.15 |
| IQVIA Holdings (IQV) | United States | $33.074B | 18.69 |
| Mettler-Toledo (MTD) | United States | $26.313B | 31.29 |
| STERIS (STE) | Ireland | $22.465B | 24.74 |
| Waters (WAT) | United States | $18.043B | 25.46 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.167B | 0.00 |
| Hologic (HOLX) | United States | $14.717B | 15.99 |
| Sysmex ADR (SSMXY) | Japan | $10.575B | 30.00 |
| Penumbra (PEN) | United States | $8.797B | 64.71 |
| Masimo (MASI) | United States | $8.618B | 31.79 |
| Globus Medical (GMED) | United States | $7.316B | 17.43 |
| Glaukos (GKOS) | United States | $5.358B | 0.00 |
| Teleflex (TFX) | United States | $5.103B | 8.42 |
| Integer Holdings (ITGR) | United States | $3.826B | 19.09 |
| TransMedics (TMDX) | United States | $3.546B | 77.08 |
| PROCEPT BioRobotics (PRCT) | United States | $2.979B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.399B | 14.28 |
| Nihon Kohden (NHNKY) | Japan | $2.020B | 23.17 |
| Elekta AB (EKTAY) | Sweden | $1.937B | 17.41 |
| Veracyte (VCYT) | United States | $1.916B | 26.89 |
| Alphatec Holdings (ATEC) | United States | $1.590B | 0.00 |
| Artivion (AORT) | United States | $1.345B | 126.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.112B | 0.00 |
| OPKO Health (OPK) | United States | $1.071B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.999B | 5.31 |
| Pulse Biosciences (PLSE) | United States | $0.990B | 0.00 |
| SiBone (SIBN) | United States | $0.759B | 0.00 |
| IRadimed (IRMD) | United States | $0.735B | 37.29 |
| Beta Bionics (BBNX) | United States | $0.636B | 0.00 |
| AxoGen (AXGN) | United States | $0.612B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.548B | 8.53 |
| OrthoPediatrics (KIDS) | United States | $0.541B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.505B | 10.86 |
| Pacific Biosciences Of California (PACB) | United States | $0.462B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.452B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.422B | 9.82 |
| Delcath Systems (DCTH) | United States | $0.380B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.371B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.352B | 0.00 |
| RxSight (RXST) | United States | $0.318B | 0.00 |
| Neuronetics (STIM) | United States | $0.296B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
| NeuroPace (NPCE) | United States | $0.288B | 0.00 |
| 908 Devices (MASS) | United States | $0.249B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.246B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.240B | 14.52 |
| CVRx (CVRX) | United States | $0.215B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.202B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.179B | 0.00 |
| Inogen (INGN) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Accuray (ARAY) | United States | $0.154B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.121B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.119B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.117B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.115B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.088B | 53.30 |
| EnVVeno Medical (NVNO) | United States | $0.086B | 0.00 |
| Hyperfine (HYPR) | United States | $0.082B | 0.00 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| Spectral AI (MDAI) | United States | $0.064B | 0.00 |
| Positron (POSC) | United States | $0.060B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.054B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.052B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.013B | 0.00 | |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 14.94 |